State
of New York
|
1-10113
|
11-0853640
|
(State
of Other Jurisdiction
|
(Commission
File Number)
|
(I.R.S.
Employer
|
of
Incorporation)
|
|
Identification
Number)
|
› |
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR
230.425)
|
› |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17CFR
240.14a-12)
|
› |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act
(17CFR240.14d-2(b))
|
› |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act
(17CFR
240.13e- 4(c))
|
Exhibit
Number
|
Description |
99.1 |
Press
Release dated July 14, 2005 Announcing Results for Second
Quarter ended June 30, 2005.
|
ACURA PHARMACEUTICALS, INC. | ||
|
|
|
Date: July 14, 2005 | By: | /s/ Peter A. Clemens |
Peter A. Clemens |
||
Vice President & Chief Financial Officer |
Exhibit
Number
|
Description |
99.1 |
Press
Release dated July 14, 2005 Announcing Results for Second
Quarter ended June 30, 2005.
|